419 related articles for article (PubMed ID: 38132121)
1. The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression.
Souza VGP; Forder A; Pewarchuk ME; Telkar N; de Araujo RP; Stewart GL; Vieira J; Reis PP; Lam WL
Cells; 2023 Dec; 12(24):. PubMed ID: 38132121
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral microbiota: implications for cancer onset, progression, and therapy.
Wu J; Zhang P; Mei W; Zeng C
Front Immunol; 2023; 14():1301506. PubMed ID: 38292482
[TBL] [Abstract][Full Text] [Related]
3. Host-Microbiome Interaction in Lung Cancer.
Dong Q; Chen ES; Zhao C; Jin C
Front Immunol; 2021; 12():679829. PubMed ID: 34108973
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment.
Zhou D; Li Y
Gut Microbes; 2023 Dec; 15(2):2276314. PubMed ID: 37943609
[TBL] [Abstract][Full Text] [Related]
6. Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.
Zhou X; You L; Xin Z; Su H; Zhou J; Ma Y
J Transl Med; 2023 Nov; 21(1):800. PubMed ID: 37950236
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
8. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.
Jiang S; Ma W; Ma C; Zhang Z; Zhang W; Zhang J
Gut Microbes; 2024; 16(1):2341717. PubMed ID: 38717360
[TBL] [Abstract][Full Text] [Related]
9. Tumor microbiome - an integral part of the tumor microenvironment.
Ciernikova S; Sevcikova A; Stevurkova V; Mego M
Front Oncol; 2022; 12():1063100. PubMed ID: 36505811
[TBL] [Abstract][Full Text] [Related]
10. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
[TBL] [Abstract][Full Text] [Related]
11. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
Liu L; Shah K
JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
[TBL] [Abstract][Full Text] [Related]
12. Microbiome Conundrum in Colon Cancer: Development, Progression, and Therapeutics.
Malla RR
Crit Rev Oncog; 2020; 25(2):129-139. PubMed ID: 33389862
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral microbiota: new frontiers in tumor immunity.
Zhang Z; Liao Y; Tang D
Carcinogenesis; 2022 Sep; 43(8):719-727. PubMed ID: 35868230
[TBL] [Abstract][Full Text] [Related]
15. Unexpected guests in the tumor microenvironment: microbiome in cancer.
Wong-Rolle A; Wei HK; Zhao C; Jin C
Protein Cell; 2021 May; 12(5):426-435. PubMed ID: 33296049
[TBL] [Abstract][Full Text] [Related]
16. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities.
Wang M; Yu F; Li P
Front Immunol; 2023; 14():1269054. PubMed ID: 37868956
[TBL] [Abstract][Full Text] [Related]
17. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
Chen Y; Liu B; Wei Y; Kuang DM
Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
[TBL] [Abstract][Full Text] [Related]
18. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
Front Immunol; 2021; 12():612826. PubMed ID: 33841394
[TBL] [Abstract][Full Text] [Related]
19. Lung microbiome: an emerging player in lung cancer pathogenesis and progression.
Karvela A; Veloudiou OZ; Karachaliou A; Kloukina T; Gomatou G; Kotteas E
Clin Transl Oncol; 2023 Aug; 25(8):2365-2372. PubMed ID: 36995519
[TBL] [Abstract][Full Text] [Related]
20. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
Wang M; Zhang L; Chang W; Zhang Y
Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
